Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced its continued ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...

The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.

Q4 2024 Management View CEO Adam Steensberg emphasized 2024 as a transformational year for Zealand Pharma, highlighting significant clinical advancements in its obesity pipeline, particularly with ...

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Currently More Than 400 Clinical Trials Studies Are Active In Saudi Arabia Says Kuick Research In New Research ReportDelhi, ...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...

The FARE Innovation Award Diagnostic Challenge is made possible through generous support from the Naddisy Foundation, the ...